Medix and DGA will await the decision of the Office of Competition and Consumer Protection (UOKiK). The Authority initially reviewed the acquisition requests and forwarded them to the second stage of the procedure. Is further consolidation on the pharmaceutical market possible? UOKiK in the case of Medix acquisition DOZ – the largest pharmacy chain in…
PLL LOT, the Polish national airline, wants to develop in the pharmaceutical logistics segment. The company has started efforts to obtain the CEIV Pharma certificate, which guarantees a high standard of services offered. CEIV Pharma by the end of October? According to the company, LOT Cargo has started its efforts to obtain a certificate issued…
Clinscience, a subsidiary of Neuca, buys 100 % of shares of the Italian Exom Group. Effective September 28, 2021, Cliniscience will purchase 60 % of the shares for EUR 13.2 million, including a total of EUR 5 million in the seller’s net cash position. The remaining 40 % will be purchased by 2025, for a…
For years, the medical industry has been one of the most innovative technology fields in our country. Universities, pharmaceutical companies and medtech startups have been leading the way. Now innovations from the medical world will be able to undergo tests in a natural environment. The Neo Hospital Group is launching a Living Lab at the…
Bioceltix, one of the new hopes in the Polish biotechnology arena, has published an information memorandum stating that it plans to raise up to PLN 7.4m through a public offering of up to 360,000 new issue shares. In addition, the Wroclaw-based company plans to debut on the NewConnect stock exchange in the second quarter of…
Philips, a healthcare technology company, has a new CEO. The company in Poland will be led by Michal Grzybowski, who will also serve as director of the Connected Care division in Central and Eastern Europe, Central Asia and Russia. Michał Grzybowski becomes the new CEO of Philips Polska Michal Grzybowski has been appointed the…
Captor Therapeutics, a biopharmaceutical company working to develop drugs for cancer and autoimmune diseases, has announced the appointment of President of the Management Board. He has been appointed as Dr Tom Shepherd. Dr Shepherd joined Captor in early December 2019. At that time, he held the position of business development director. Last week, the company…
Selvita, which specialises in laboratory research and development services for external customers, has announced the conclusion of its first acquisition agreement. The Polish company will acquire 100% of shares in a Croatian company operating on the contract research market in the pre-clinical area. However, certain conditions must be met beforehand. Fidelta in Selvita’s structure in…
Jarek Oleszczuk was appointed to the board of the Polish start-up Genomtec. As Chief Business Officer (CBO) he will be responsible for further development and implementation of the business strategy. Will Oleszczuk’s experience gained in managing large pharmaceutical corporations help Genomtec to grow faster? AstraZeneca, AbbVie, Abbott, Novartis… Jarek Oleszczuk has many years of experience…
Paulina Romaniszyn was appointed as Country Head and General Manager in the Polish branch of Stada. The new Head will use the experience she has gained previously and take care of the implementation of the adopted development strategy. Experience of Romaniszyn in pharmaceutical companies Paulina Romaniszyn became the new head of the Polish branch of…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.